Drug Enforcement Administration 2005 – Federal Register Recent Federal Regulation Documents

Results 51 - 100 of 214
Schedules of Controlled Substances: Placement of Pregabalin Into Schedule V
Document Number: 05-15036
Type: Rule
Date: 2005-07-28
Agency: Drug Enforcement Administration, Department of Justice
This final rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid], including its salts, and all products containing pregabalin into Schedule V of the Controlled Substances Act (CSA). As a result of this rule, the regulatory controls and criminal sanctions of Schedule V will be applicable to the manufacture, distribution, dispensing, importation and exportation of pregabalin and products containing pregabalin.
Importer of Controlled Substances; Notice of Registration
Document Number: 05-14837
Type: Notice
Date: 2005-07-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-14836
Type: Notice
Date: 2005-07-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-14835
Type: Notice
Date: 2005-07-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-14834
Type: Notice
Date: 2005-07-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 05-14833
Type: Notice
Date: 2005-07-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 05-14832
Type: Notice
Date: 2005-07-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-14831
Type: Notice
Date: 2005-07-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-14828
Type: Notice
Date: 2005-07-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 05-14827
Type: Notice
Date: 2005-07-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 05-14826
Type: Notice
Date: 2005-07-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 05-14825
Type: Notice
Date: 2005-07-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 05-14824
Type: Notice
Date: 2005-07-27
Agency: Drug Enforcement Administration, Department of Justice
Authority for Practitioners To Dispense or Prescribe Approved Narcotic Controlled Substances for Maintenance or Detoxification Treatment
Document Number: 05-12440
Type: Rule
Date: 2005-06-23
Agency: Drug Enforcement Administration, Department of Justice
DEA is amending its regulations to allow qualified practitioners not otherwise registered as a narcotic treatment program to dispense and prescribe to narcotic dependent persons Schedule III, IV, and V narcotic controlled drugs approved by the Food and Drug Administration specifically for use in maintenance or detoxification treatment. This Final Rule is in response to amendments to the Controlled Substances Act by the Drug Addiction Treatment Act of 2000 (DATA) that are designed to expand and improve treatment of narcotic addiction. This Final Rule is intended to accomplish the goals of DATA while preventing the diversion of Schedule III, IV, and V narcotic controlled drugs approved by the Food and Drug Administration specifically for maintenance/detoxification treatment.
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-11791
Type: Notice
Date: 2005-06-15
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 05-11639
Type: Notice
Date: 2005-06-13
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-11479
Type: Notice
Date: 2005-06-10
Agency: Drug Enforcement Administration, Department of Justice
Scott H. Nearing, D.D.S., Grant of Restricted Registration
Document Number: 05-11251
Type: Notice
Date: 2005-06-07
Agency: Drug Enforcement Administration, Department of Justice
Robert A. Smith, M.D., Revocation of Registration
Document Number: 05-11250
Type: Notice
Date: 2005-06-07
Agency: Drug Enforcement Administration, Department of Justice
Joy's Ideas, Revocation of Registration
Document Number: 05-11249
Type: Notice
Date: 2005-06-07
Agency: Drug Enforcement Administration, Department of Justice
Felix K. Prakasam, M.D. Revocation of Registration
Document Number: 05-11248
Type: Notice
Date: 2005-06-07
Agency: Drug Enforcement Administration, Department of Justice
Carlin Paul Graham, Jr., M.D. Revocation of Registration
Document Number: 05-11247
Type: Notice
Date: 2005-06-07
Agency: Drug Enforcement Administration, Department of Justice
Kennard Kobrin, M.D., Revocation of Registration
Document Number: 05-11246
Type: Notice
Date: 2005-06-07
Agency: Drug Enforcement Administration, Department of Justice
Robert M. Canon, M.D., Revocation of Registration
Document Number: 05-11245
Type: Notice
Date: 2005-06-07
Agency: Drug Enforcement Administration, Department of Justice
Stuart A. Bergman, M.D., Revocation of Registration
Document Number: 05-11244
Type: Notice
Date: 2005-06-07
Agency: Drug Enforcement Administration, Department of Justice
Roger A. Rodriguez, M.D., Denial of Registration
Document Number: 05-11243
Type: Notice
Date: 2005-06-07
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-10787
Type: Notice
Date: 2005-06-01
Agency: Drug Enforcement Administration, Department of Justice
Salvatore DeFrank, D.P.M. Revocation of Registration
Document Number: 05-9838
Type: Notice
Date: 2005-05-18
Agency: Drug Enforcement Administration, Department of Justice
Katarzyna Rygiel, M.D.; Revocation of Registration
Document Number: 05-9837
Type: Notice
Date: 2005-05-18
Agency: Drug Enforcement Administration, Department of Justice
Robert A. Burkich, M.D.; Revocation of Registration
Document Number: 05-9836
Type: Notice
Date: 2005-05-18
Agency: Drug Enforcement Administration, Department of Justice
Rebecca Sotelo Denial of Registration
Document Number: 05-9835
Type: Notice
Date: 2005-05-18
Agency: Drug Enforcement Administration, Department of Justice
Lance L. Gooberman, M.D.; Denial of Registration
Document Number: 05-9834
Type: Notice
Date: 2005-05-18
Agency: Drug Enforcement Administration, Department of Justice
A-1 Distribution Wholesale; Denial of Registration
Document Number: 05-9833
Type: Notice
Date: 2005-05-18
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Pregabalin into Schedule V
Document Number: 05-9634
Type: Proposed Rule
Date: 2005-05-13
Agency: Drug Enforcement Administration, Department of Justice
This proposed rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid], including its salts, and all products containing pregabalin into Schedule V of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Acting Assistant Secretary for Health of the Department of Health and Human Services (DHHS) and on an evaluation of the relevant data by DEA. If finalized, this action will impose the regulatory controls and criminal sanctions applicable to Schedule V non-narcotics on those who handle pregabalin and products containing pregabalin.
Preventing the Accumulation of Surplus Controlled Substances at Long Term Care Facilities
Document Number: 05-9538
Type: Rule
Date: 2005-05-13
Agency: Department of Justice, Drug Enforcement Administration
DEA is amending its regulations to allow, where State laws permit, for retail pharmacy installation of automated dispensing systems at long term care facilities. Automated dispensing systems would allow dispensing of single dosage units and mitigate the problem of excess stocks and disposal.
Net Wholesale; Revocation of Registration
Document Number: 05-9282
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
Jay Enterprises of Spartanburg, Inc.; Denial of Registration
Document Number: 05-9252
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
ELK International, Inc., d.b.a. Tri-City Wholesale; Denial of Application
Document Number: 05-9251
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
James Marvin Goodrich, M.D. Revocation of Registration
Document Number: 05-9250
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
Michael J. Millette, M.D.; Revocation of Registration
Document Number: 05-9249
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
John S. Poulter, D.D.S; Revocation of Registration
Document Number: 05-9248
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
Jay D. Angeluzzi, M.D.; Revocation of Registration
Document Number: 05-9247
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
Stephen K. Jones, M.D.; Denial of Registration
Document Number: 05-9246
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
Thomas J. Mulhearn, III, M.D.; Revocation of Registration
Document Number: 05-9245
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
Robert A. Smith, M.D.; Revocation of Registration
Document Number: 05-9244
Type: Notice
Date: 2005-05-10
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-9177
Type: Notice
Date: 2005-05-09
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-8694
Type: Notice
Date: 2005-05-02
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-8693
Type: Notice
Date: 2005-05-02
Agency: Drug Enforcement Administration, Department of Justice
Definition and Registration of Reverse Distributors
Document Number: 05-8692
Type: Rule
Date: 2005-05-02
Agency: Drug Enforcement Administration, Department of Justice
DEA is finalizing, without change, the interim rule with Request for Comment published in the Federal Register July 11, 2003 at 68 FR 41222. The interim final rule amended Title 21, Code of Federal Regulations, parts 1300, 1301, 1304, 1305 and 1307 to define the term ``reverse distributor'' and establish a new category of registration for persons handling controlled substances. The amendments established the regulatory standards under which reverse distributors may handle unwanted, unusable, or outdated controlled substances acquired from another DEA registrant. These standards ensure the proper documentation and recordkeeping necessary to prevent diversion of such controlled substances to illegal purposes. This final rule makes these changes permanent.
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-8680
Type: Notice
Date: 2005-05-02
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.